Alterity Therapeutics (ATHE) Restructuring Costs (2014 - 2025)
Alterity Therapeutics (ATHE) posted quarterly Restructuring Costs of $300347.2 for Q4 2025, up 1.98% year-over-year from $294528.3 in Q4 2024, and up 1.98% quarter-over-quarter from $294528.3 in Q4 2024.
Alterity Therapeutics (ATHE) Restructuring Costs (2014 - 2025) Analysis & Trends
Alterity Therapeutics' Restructuring Costs history runs 11 years deep, the most recent figure standing at $300347.2 for Q4 2025.
- In Q4 2025, Restructuring Costs rose 1.98% year-over-year to $300347.2; the TTM figure through Dec 2025 stood at $880752.6 (up 19.17% YoY), while the FY2024 annual figure was $520.9 billion, up 70.45% from the prior year.
- Restructuring Costs for Q4 2025 stood at $300347.2, up from $294528.3 in the prior quarter.
- The five-year high for Restructuring Costs was $300347.2 in Q4 2025, with the low at $126118.3 in Q4 2023.
- The 5-year median for Restructuring Costs is $159758.8 (2022), against an average of $207880.5.
- The sharpest annual moves came in 2023 and 2024: Restructuring Costs declined 21.06% in 2023, then surged 133.53% in 2024.
- Alterity Therapeutics' Restructuring Costs stood at $158650.0 in 2021, then grew by 0.7% to $159758.8 in 2022, then slipped by 21.06% to $126118.3 in 2023, then soared by 133.53% to $294528.3 in 2024, then gained by 1.98% to $300347.2 in 2025.
- Business Quant data shows ATHE's Restructuring Costs at $300347.2 in Q4 2025, $294528.3 in Q4 2024, and $126118.3 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.46 Bn | 78.47 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.62 Bn | 60.44 Bn | 1.37 Bn |
| 4 | Moderna | 58.37 Bn | 53.24 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.73 Bn | 28.43 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.27 Bn | 9.87 Bn | 668.28 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.23 Bn | 26.40 Bn | - |
| 10 | Alterity Therapeutics | 48.99 Mn | 16.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 300,347.20 |
| Dec 31, 2024 | 294,528.32 |
| Dec 31, 2023 | 126,118.34 |
| Dec 31, 2022 | 159,758.79 |
| Dec 31, 2021 | 158,649.98 |
| Dec 31, 2019 | 132,927.38 |
| Dec 31, 2018 | 126,780.47 |
| Jun 30, 2018 | 108.95 Mn |
| Dec 31, 2017 | 158,781.85 |
| Dec 31, 2016 | 159,270.63 |
| Dec 31, 2015 | 617,604.24 |
| Dec 31, 2014 | -1.88 Mn |